Terms: = Brain cancer AND CDKN1B, CDKN4, 1027, ENSG00000111276, MEN4, P27KIP1, P46527, MEN1B, KIP1 AND Prognosis
21 results:
1. PRMT6-CDC20 facilitates glioblastoma progression via the degradation of cdkn1b.
Wang J; Xiao Z; Li P; Wu C; Li Y; Wang Q; Chen Y; Zhou H; Li Z; Wang Z; Lan Q; Wang Y
Oncogene; 2023 Mar; 42(14):1088-1100. PubMed ID: 36792756
[TBL] [Abstract] [Full Text] [Related]
2. MicroRNA-575 acts as a novel oncogene via targeting multiple signaling pathways in glioblastoma.
Gray A; Cui T; Bell EH; McElroy J; Sebastian E; Li F; Geurts M; Liu K; Robe P; Haque SJ; Chakravarti A
Exp Mol Pathol; 2022 Oct; 128():104813. PubMed ID: 35901926
[TBL] [Abstract] [Full Text] [Related]
3. Loss of deubiquitylase USP2 triggers development of glioblastoma via TGF-β signaling.
Tu Y; Xu L; Xu J; Bao Z; Tian W; Ye Y; Sun G; Miao Z; Chao H; You Y; Liu N; Ji J
Oncogene; 2022 Apr; 41(18):2597-2608. PubMed ID: 35332268
[TBL] [Abstract] [Full Text] [Related]
4. Genomics and Epigenomics of Pituitary Tumors: What Do Pathologists Need to Know?
Asa SL; Mete O; Ezzat S
Endocr Pathol; 2021 Mar; 32(1):3-16. PubMed ID: 33433883
[TBL] [Abstract] [Full Text] [Related]
5. Uronic acid metabolic process-related gene expression-based signature predicts overall survival of glioma.
Feng Y; Li G; Shi Z; Yan X; Li R; Zhai Y; Chang Y; Wang D; Kahlert UD; Zhang W; Yuan F
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33324981
[TBL] [Abstract] [Full Text] [Related]
6. The novel chromatin architectural regulator SND1 promotes glioma proliferation and invasion and predicts the prognosis of patients.
Yu L; Xu J; Liu J; Zhang H; Sun C; Wang Q; Shi C; Zhou X; Hua D; Luo W; Bian X; Yu S
Neuro Oncol; 2019 Jun; 21(6):742-754. PubMed ID: 30753603
[TBL] [Abstract] [Full Text] [Related]
7. Integrated Cox's model for predicting survival time of glioblastoma multiforme.
Ai Z; Li L; Fu R; Lu JM; He JD; Li S
Tumour Biol; 2017 Apr; 39(4):1010428317694574. PubMed ID: 28381184
[TBL] [Abstract] [Full Text] [Related]
8. LIM domain only 2 induces glioma invasion via cytosolic p27(kip1).
Park CG; Sohn YW; Kim EJ; Kim SH; Kim SC; Kim H
Tumour Biol; 2016 Feb; 37(2):2473-80. PubMed ID: 26383528
[TBL] [Abstract] [Full Text] [Related]
9. Decreased expression and prognostic role of cytoplasmic BRSK1 in human breast carcinoma: correlation with Jab1 stability and PI3K/Akt pathway.
Wang H; Liu XB; Chen JH; Wang QQ; Chen JP; Xu JF; Sheng CY; Ni QC
Exp Mol Pathol; 2014 Oct; 97(2):191-201. PubMed ID: 25036402
[TBL] [Abstract] [Full Text] [Related]
10. Spy1 is frequently overexpressed in malignant gliomas and critically regulates the proliferation of glioma cells.
Zhang L; Shen A; Ke Q; Zhao W; Yan M; Cheng C
J Mol Neurosci; 2012 Jul; 47(3):485-94. PubMed ID: 22447439
[TBL] [Abstract] [Full Text] [Related]
11. Expression of epidermal growth factor receptor and HER-2 in pediatric embryonal brain tumors.
Patereli A; Alexiou GA; Stefanaki K; Moschovi M; Doussis-Anagnostopoulou I; Prodromou N; Karentzou O
Pediatr Neurosurg; 2010; 46(3):188-92. PubMed ID: 20962551
[TBL] [Abstract] [Full Text] [Related]
12. Defective DNA double-strand break repair underlies enhanced tumorigenesis and chromosomal instability in p27-deficient mice with growth factor-induced oligodendrogliomas.
See WL; Miller JP; Squatrito M; Holland E; Resh MD; Koff A
Oncogene; 2010 Mar; 29(12):1720-31. PubMed ID: 20062078
[TBL] [Abstract] [Full Text] [Related]
13. Molecular pharmacology of phosphatidylinositol 3-kinase inhibition in human glioma.
Guillard S; Clarke PA; Te Poele R; Mohri Z; Bjerke L; Valenti M; Raynaud F; Eccles SA; Workman P
Cell Cycle; 2009 Feb; 8(3):443-53. PubMed ID: 19177002
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic implication of p27 expression in primary central nervous system lymphoma.
Kunishio K; Nagao S
Brain Tumor Pathol; 2006 Oct; 23(2):77-81. PubMed ID: 18095123
[TBL] [Abstract] [Full Text] [Related]
15. Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma.
Yu J; Zhang H; Gu J; Lin S; Li J; Lu W; Wang Y; Zhu J
BMC Cancer; 2004 Sep; 4():65. PubMed ID: 15367334
[TBL] [Abstract] [Full Text] [Related]
16. Pleomorphic xanthoastrocytomas: immunohistochemistry, grading and clinico-pathologic correlations. An analysis of 34 cases from a single Institute.
Korshunov A; Golanov A
J Neurooncol; 2001 Mar; 52(1):63-72. PubMed ID: 11451204
[TBL] [Abstract] [Full Text] [Related]
17. High cyclin E/low p27kip1 expression is associated with poor prognosis in astrocytomas.
Tamiya T; Mizumatsu S; Ono Y; Abe T; Matsumoto K; Furuta T; Ohmoto T
Acta Neuropathol; 2001 Apr; 101(4):334-40. PubMed ID: 11355304
[TBL] [Abstract] [Full Text] [Related]
18. Immunohistochemical markers for intracranial ependymoma recurrence. An analysis of 88 cases.
Korshunov A; Golanov A; Timirgaz V
J Neurol Sci; 2000 Aug; 177(1):72-82. PubMed ID: 10967185
[TBL] [Abstract] [Full Text] [Related]
19. p27/kip1 expression in oligodendrogliomas and its possible prognostic role.
Cavalla P; Piva R; Bortolotto S; Grosso R; Cancelli I; Chiò A; Schiffer D
Acta Neuropathol; 1999 Dec; 98(6):629-34. PubMed ID: 10603039
[TBL] [Abstract] [Full Text] [Related]
20. Proteasome-dependent degradation of p27/kip1 in gliomas.
Piva R; Cancelli I; Cavalla P; Bortolotto S; Dominguez J; Draetta GF; Schiffer D
J Neuropathol Exp Neurol; 1999 Jul; 58(7):691-6. PubMed ID: 10411338
[TBL] [Abstract] [Full Text] [Related]
[Next]
